Shilpa Medicare announced that United States Food and Drugs Administration (USFDA) had conducted an inspection at Unit-2 of Shilpa Pharma Lifesciences, located at Raichur from 10 March to 14 March 2025.
The inspection was closed with ZERO observations. This is second consecutive ZERO 483 inspection from USFDA at this site.
Low Price Shares
0 mins read . Dec 18, 2024
Nifty 50 Top 10 Stocks
0 mins read . Dec 18, 2024
Best Stocks in 2025
0 mins read . Dec 18, 2024
Explore our products
Unlimited Trading starting at ₹249
Open Trading Account
